Growth hormone treatment and the risk of adolescent scoliosis: A large matched cohort study

Abstract

Recombinant human growth hormone treatment was associated with an increased risk to be diagnosed with adolescent scoliosis in males. Scoliosis development should be monitored appropriately in rhGH recipients.